AACE Podcasts

Join endocrine expert Vin Tangpricha, MD, PhD, MACE, as he moderates a discussion with Janet McGill, MD, MA, FACP, MACE and Amy C. Donihi, PharmD, BC-ADM, FCCP, two members of the task force behind the AACE Consensus Statement: Use of Diabetes Technology for Management of Adults with Diabetes. They explain how this multidisciplinary update builds on the 2021 guidelines to deliver concise, evidence-informed recommendations for shared decision-making and guide clinicians in integrating advanced glucose-sensing and insulin-delivery technologies into everyday practice.

Join us for this episode as Arvind R. Cavale, MD, FACE, FCPP, PCEO and Kevin McKinney, MD, FACE explore how endocrinologists can influence the state and regional decisions that shape patient access and endocrine care in their communities. Speakers will discuss how to identify local policy opportunities, build relationships with decision-makers, collaborate with medical societies and community partners, and mobilize others around a shared goal.

Join endocrine expert and Endocrine Practice Associate Editor, Dr. Cecilia M. Lansang, as she interviews Dr. Guillermo E. Umpierrez, professor of medicine at Emory University School of Medicine, clinician educator and researcher, for a candid conversation about his journey in medicine, endocrinology, and inpatient diabetes care. Dr. Umpierrez reflects on his early work studying diabetic ketoacidosis and ketosis-prone diabetes, the mentors and teams who shaped his academic career, and the importance of finding the right environment, enjoying the work and celebrating small successes along the way. To learn more, read Dr. Umpierrez’s review article in Endocrine Practice: Ketosis-Prone Type 2 Diabetes Mellitus: 3 Decades of Clinical, Pathophysiologic, and Therapeutic Insights.

Join endocrine expert and Endocrine Practice Associate Editor, Dr. Melissa Putman as she interviews renowned endocrinologist and diabetes researcher Dr. David Nathan for a candid and inspiring conversation reflecting on more than five decades of groundbreaking work in diabetes research and patient care. Together, they discuss Dr. Nathan’s remarkable career, including his work on the DCCT, diabetes prevention, and early GLP studies, while also exploring the future of diabetes research and advice for the next generation of researchers. To learn more, read Dr. Nathan’s review article in Endocrine Practice: Goodbye to All That? Personal Reflections on 50 years of Diabetes Research: Right Time, Right Place, Great Colleagues and Unwavering NIH Support.

Join endocrinologist Elizabeth Bauer, MD, FACP, FACE, DABOM, as she speaks with Michelle about her experience living with obesity, including the challenges, stigma, and turning points that shaped her path. Together, they explore the AACE Journey for Patients With Obesity, as Michelle shares which parts she found most helpful for understanding obesity as a chronic disease and navigating next steps. Don’t miss this inspiring discussion, brought to you with the support of Boehringer-Ingelheim, Lilly, Novo Nordisk, and Amgen.

Join endocrine expert Vin Tangpricha, MD, PhD, as he moderates a discussion with members of the task force behind the updated 2026 AACE Consensus Statement: Algorithm for the Management of Adults with Type 2 Diabetes. AACE Past President and Chair Susan L. Samson, MD, PhD, FRCPC, FACE, is joined by Vice Chair Priyathama Vellanki, MD, along with Lawrence Blonde, MD, FACP, MACE, and Irl B. Hirsch, MD, MACP, to discuss key changes. Together, they explore how the new algorithm supports more individualized, complications-focused care and provides practical guidance clinicians can apply in everyday practice.

Join Dr. Steven Petak, Past President of AACE and ISCD and former Chief of Endocrinology at Houston Methodist Hospital, as he leads an in-depth conversation on Hypophosphatemia with Dr. Laila Tabatabai, Associate Professor of Clinical Medicine at Weill Cornell and metabolic bone specialist at Houston Methodist, and Dr. Basma Abdulhadi, Assistant Professor of Medicine at the University of Alabama at Birmingham and head of bone densitometry. Together, they discuss how to distinguish Hypophosphatemia from osteoporosis and osteomalacia, recognize key symptoms across ages, and apply a focused diagnostic workup. The discussion also highlights FGF23-mediated disorders, XLH, and current treatment approaches including burosumab, reinforcing a key reminder for clinicians to check phosphate levels to help prevent missed diagnoses. This episode is made possible through a sponsorship from Kyowa Kirin.Kyowa Kirin was not involved in the content of the podcast.

Join Dr. Bahar Force, Endocrinologist, Medical Director of the Pituitary Center, and Associate Program Director of the Endocrinology Fellowship Program at Baylor College of Medicine, as she speaks with leading experts Dr. James Findling, Clinical Professor of Endocrinology at the Medical College of Wisconsin, and Dr. Ty Carroll, Visiting Professor of Endocrinology and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Wisconsin Madison, for a clinician-focused conversation on non-neoplastic hypercortisolism. Together, they discuss how common conditions can lead to cortisol elevations that resemble Cushing syndrome, the clinical patterns that raise concern for neoplastic hypercortisolism, and the growing role of the Desmopressin Stimulation Test in helping distinguish between the two. The episode also highlights emerging research, including insights from the Catalyst study and the potential role of cortisol-directed therapy. 

Join endocrine expert Dr. David Lieb as he moderates a discussion with Dr. Karl Nadolsky, Chair of the AACE Obesity Algorithm, and Dr. Timothy Garvey, Vice Chair, as they review the 2025 AACE Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease and highlight key updates since 2016. The experts discuss advances in pharmacotherapy, the evolution of complication-centric and person-centered care, and strategies to reduce weight bias in clinical practice. They also share guidance on individualizing therapy and look ahead to the future of obesity medications as new treatments emerge.

Join endocrine expert Dr. David Lieb as he moderates a discussion with Dr. Shailendra Patel, Chair of the 2025 AACE Dyslipidemia Algorithm; Dr. Maria Belalcazar, Vice Chair; and Dr. Robert Hegele, Author and Representative of the Canadian Cardiovascular Society, about the 2025 Updated Algorithm for Management of Adults with Dyslipidemia.This episode covers:The rationale behind updating the algorithm and how it aligns with the 2025 Clinical Practice Guideline for the Pharmacologic Management of Adults with DyslipidemiaKey updates from the 2020 algorithm, including expanded guidance on hypertriglyceridemia and lipid management in special populationsPractical strategies for integrating the algorithm into everyday clinical practice and medical education with an emphasis on patient-centered care, shared decision making, and health equityEmerging therapies on the horizon and priority areas for future research Tune in to hear expert insights on how this updated, evidence-based resource can support better clinical decision making and improve patient outcomes.